Radiation in addition to endocrine treatment following BCS in low risk breast cancer patients (<3 cm diameter, hormone receptor positive, N0, postmenopausal) substantially reduces the hazard to develop a local recurrence by a factor of 6.8 (CI 4.4–11.9; p < 0,001) (Fig. 2). This evidence concerns the gene NR4A1 and breast carcinoma.